TRAW Q1 2026 Losses $7.1M, $0 Revenue, EPS -$0.53
Traws Pharma, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $1.47
-19% in 7d after detection
Post-detection moves
1h
—
1d
-6.4%
3d
-14%
7d
-19%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS